Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Biden Discusses More Details on Cancer Moonshot Initiative

By Drug Discovery Trends Editor | January 20, 2016

Drop of Light/ Shutterstock.comVice President Joe Biden revealed more information today regarding the plan to cure cancer he was placed in charge of during last week’s State of the Union.

He called for quicker drug approvals during a panel at this year’s World Economic Forum in Davos, Switzerland. Part of the initiative would involve expediting the process of bringing new types of immunotherapies to market, reports Reuters.

Biden told the audience he recently met with the head of the Food and Drug Administration (FDA) and three unnamed drug companies at his home to discuss the plan, in which both sides agreed to do more to help patients receive potent therapies.

Immunotherapies have shown significant promise in using the human body’s natural defenses to fend off cancer, but Reuters explains that these drugs can be very expensive (reaching up to $100,000 a year per patient) while pharmaceutical firms have been reticent in divulging information on early-stage medical experiments.

READ MORE: Biden Reveals Details on Cancer Moonshot Project

The Vice President called for cancer researchers to help “learn what it would take to make major progress” on beating the disease so he can better educate the public about what steps need to be taken, according to Stat News.

He told the crowd “My job…is to educate the public in very simple language why I’m going to ask so much more of them — a lot more money, a lot more tax dollars, a lot more cooperation.”

Data sharing will be a core component of this program, too. Biden is seeking a way to build a data infrastructure to enable better sharing of medical information, but it was acknowledged during the panel that privacy concerns could be an impediment, writes Stat News.

Biden has made finding a cure for cancer his personal mission after losing his son Beau to a brain tumor last year.

Cancer researchers have expressed concerns that this strategy is presenting an “over-simplified” solution for a complex problem. It would take more than one designated “cure” to eliminate all forms of this condition, they say. 


Filed Under: Drug Discovery

 

Related Articles Read More >

If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
Antibody - visual concept of immune System - 3D illustration
Fresenius picks the biosimilars, WuXi Biologics builds them in a deal covering up to 37 candidates
Physician in a white coat reviewing information on a tablet with a patient in an exam room.
What real-world data shows about current cancer care
Roche Towers, Basel, Switzerland
Roche picks cancer targets, Hansoh builds the ADCs in deal with $400 million upfront
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE